Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes
- 1 June 1989
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 339 (6226) , 625-626
- https://doi.org/10.1038/339625a0
Abstract
ONE mechanism by which the immune system develops the ability to discriminate self from nonself is the deletion of autoreactive T-cell clones during thymic maturation1–4. The drug cyclosporin A (CsA) has been shown to interfere with this process, allowing the escape of normally 'forbidden' T-cell clones5,6 and the appearance of autoimmune disease7–10. Recently, it has been demonstrated that immature thymocytes undergo programmed cell death (apoptosis) upon activation via the T-cell receptor11. A similar phenomenon of activation-induced cell death (AICD) has been observed in T-cell hybridomas12,13. Here we show that AICD in T-cell hybridomas in vitro and in thymocytes in vivo is blocked by CsA. Thus, clonal deletion may involve AICD when self-reactive, immature T cells are induced by self antigen, and CsA may cause autoimmunity by interfering with this process.Keywords
This publication has 16 references indexed in Scilit:
- Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic culturesNature, 1989
- Abnormal differentiation of thymocytes in mice treated with cyclosporin ANature, 1988
- Effects of Cyclosporine A on T Cell Development and Clonal DeletionScience, 1988
- Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytesNature, 1988
- Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice.The Journal of Experimental Medicine, 1988
- Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complexNature, 1988
- A T cell receptor Vβ segment that imparts reactivity to a class II major histocompatibility complex productCell, 1987
- Cell growth cycle block of T cell hybridomas upon activation with antigen.The Journal of Experimental Medicine, 1987
- Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.The Journal of Experimental Medicine, 1985
- Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.The Journal of Experimental Medicine, 1983